Novel biosensor detects circulating tumor DNA, highlighting its potential for clinical diagnostics.
In this work, a novel hydrothermal-calcination process was introduced for the fabrication of sheet-like α-Fe 2 O 3 /Fe 3 O 4 magnetic nanocomposites with an average diameter of 220 nm, average thickness of 130 nm, and saturation magnetization of 27.6 emu∙g -1 . With the nanosheets as the precursors, the α-Fe 2 O 3 /Fe 3 O 4 @Au-ssDNA/BSA probes with label-free and magnetically induced self-assembly were constructed for the detection of circulating tumor DNA. The probes revealed excellent linear relationship as I = -2.62 lgC ctDNA +138.35 (the linear range of 10 pM–1 μM for the concentration of circulating tumor DNA) with an R 2 of 0.998, lower limit of detection of 229 fM, and limit of quantification of 763 fM. The biosensors revealed superior reproducibility (relative standard deviation of 1.13%), excellent stability (the detection errors of -0.97%–1.47% in 14 days), and high selectivity, suggesting the significant clinical application value in the detection of circulating tumor DNA for the biosensors.
No takes yet. Share an insight, caveat, or question.
Bai et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: